Patent Act P-4
Section 83, as amended by S.C. 2017, c. 6, s. 50
- Earlier version
- In force until June 29, 2021
- Later version
- In force since June 30, 2021 (version in force)
Text deletedText added
Marginal note:Order re excessive prices
83 (1) Start of deletion Where End of deletionStart of insertion If End of insertionthe Board finds that a Start of deletion patentee of End of deletionStart of insertion rights holder for End of insertionan invention pertaining to a medicine is selling the medicine in any market in Canada at a price that, in the Board’s opinion, is excessive, the Board may, by order, direct the Start of deletion patentee End of deletionStart of insertion rights holder End of insertionto cause the maximum price at which the Start of deletion patentee End of deletionStart of insertion rights holder End of insertionsells the medicine in that market to be reduced to Start of deletion such End of deletionStart of insertion the End of insertionlevel Start of deletion as End of deletionStart of insertion that End of insertionthe Board considers not to be excessive and Start of deletion as End of deletionStart of insertion that End of insertionis specified in the order.
Start of deletion Idem End of deletionStart of insertion Order re excessive prices End of insertion
(2) Subject to subsection (4), Start of deletion where End of deletionStart of insertion if End of insertionthe Board finds that a Start of deletion patentee of End of deletionStart of insertion rights holder for End of insertionan invention pertaining to a medicine has, while a Start of deletion patentee End of deletionStart of insertion rights holder End of insertion, sold the medicine in any market in Canada at a price that, in the Board’s opinion, was excessive, the Board may, by order, direct the Start of deletion patentee End of deletionStart of insertion rights holder End of insertionto do any one or more of the following things Start of deletion as End of deletionStart of insertion that End of insertionwill, in the Board’s opinion, offset the amount of the excess revenues estimated by it to have been derived by the Start of deletion patentee End of deletionStart of insertion rights holder End of insertionfrom the sale of the medicine at an excessive price:
(a) reduce the price at which the Start of deletion patentee End of deletionStart of insertion rights holder End of insertionsells the medicine in any market in Canada, to Start of deletion such End of deletionStart of insertion the End of insertionextent and for Start of deletion such End of deletionStart of insertion the End of insertionperiod Start of deletion as is End of deletionStart of insertion that are End of insertionspecified in the order;
(b) Start of insertion to the extent and for the period that are specified in the order, End of insertionreduce the price at which the Start of deletion patentee End of deletionStart of insertion rights holder End of insertionsellsStart of deletion one End of deletionStart of insertion , in any market in Canada, any End of insertionother medicine to which a patented inventionStart of insertion , or invention protected by a certificate of supplementary protection, End of insertionof the Start of deletion patentee End of deletionStart of insertion rights holder End of insertionpertainsStart of deletion in any market in Canada, to such extent and for such period as is specified in the order End of deletion;Start of deletion or End of deletion
(c) pay to Her Majesty in right of Canada an amount Start of insertion that is End of insertionspecified in the order.
Start of deletion Idem End of deletionStart of insertion Order re excessive prices End of insertion
(3) Subject to subsection (4), Start of deletion where End of deletionStart of insertion if End of insertionthe Board finds that a former Start of deletion patentee of End of deletionStart of insertion rights holder for End of insertionan invention pertaining to a medicine had, while a Start of deletion patentee End of deletionStart of insertion rights holder End of insertion, sold the medicine in any market in Canada at a price that, in the Board’s opinion, was excessive, the Board may, by order, direct the former Start of deletion patentee End of deletionStart of insertion rights holder End of insertionto do any one or more of the following things Start of deletion as End of deletionStart of insertion that End of insertionwill, in the Board’s opinion, offset the amount of the excess revenues estimated by it to have been derived by the former Start of deletion patentee End of deletionStart of insertion rights holder End of insertionfrom the sale of the medicine at an excessive price:
(a) Start of insertion to the extent and for the period that are specified in the order, End of insertionreduce the price at which the former Start of deletion patentee End of deletionStart of insertion rights holder End of insertionsellsStart of insertion , in any market in Canada, End of insertiona medicine to which a patented inventionStart of insertion , or invention protected by a certificate of supplementary protection, End of insertionof the former Start of deletion patentee End of deletionStart of insertion rights holder End of insertionpertainsStart of deletion in any market in Canada, to such extent and for such period as is specified in the order End of deletion; or
(b) pay to Her Majesty in right of Canada an amount Start of insertion that is End of insertionspecified in the order.
Start of deletion Where End of deletionStart of insertion If End of insertionpolicy to sell at excessive price
(4) Start of deletion Where End of deletionStart of insertion If End of insertionthe Board, having regard to the extent and duration of the sales of the medicine at an excessive price, is of the opinion that the Start of deletion patentee End of deletionStart of insertion rights holder End of insertionor former Start of deletion patentee End of deletionStart of insertion rights holder End of insertionhas engaged in a policy of selling the medicine at an excessive price, the Board may, by order, in lieu of any order it may make under subsection (2) or (3), as the case may be, direct the Start of deletion patentee End of deletionStart of insertion rights holder End of insertionor former Start of deletion patentee End of deletionStart of insertion rights holder End of insertionto do any one or more of the things referred to in that subsection Start of deletion as End of deletionStart of insertion that End of insertionwill, in the Board’s opinion, offset not more than twice the amount of the excess revenues estimated by it to have been derived by the Start of deletion patentee End of deletionStart of insertion rights holder End of insertionor former Start of deletion patentee End of deletionStart of insertion rights holder End of insertionfrom the sale of the medicine at an excessive price.
Marginal note:Excess revenues
(5) In estimating the amount of excess revenues under subsection (2), (3) or (4), the Board shall not consider any revenues derived by a Start of deletion patentee End of deletionStart of insertion rights holder End of insertionor former Start of deletion patentee End of deletionStart of insertion rights holder End of insertionbefore December 20, 1991 or any revenues derived by a former Start of deletion patentee End of deletionStart of insertion rights holder End of insertionafter Start of deletion the former patentee End of deletionStart of insertion they End of insertionceased to be entitled to the benefit of the patent or Start of insertion certificate of supplementary protection, as the case may be, or End of insertionto exercise any rights in relation to the patent Start of insertion or certificate End of insertion.
Marginal note:Right to hearing
(6) Before the Board makes an order under this section, it shall provide the Start of deletion patentee End of deletionStart of insertion rights holder End of insertionor former Start of deletion patentee End of deletionStart of insertion rights holder End of insertionwith a reasonable opportunity to be heard.
Marginal note:Limitation period
(7) No order may be made under this section in respect of a former Start of deletion patentee End of deletionStart of insertion rights holder End of insertionwho, more than three years before the day on which the proceedings in the matter commenced, ceased to be entitled to the benefit of the patent or Start of insertion certificate of supplementary protection, as the case may be, or End of insertionto exercise any rights in relation to the patent Start of insertion or certificate End of insertion.
Read the provisionHistory of the ActShow the text in English and French, side by side
Unofficial reproduction of the consolidated text published by the Department of Justice Canada, permitted by the Reproduction of Federal Law Order. Only the official text is authoritative.